From Surenda Srinivas of the Tata Memorial Hospital in Mumbai they have managed to launch the screening program that has so far managed to decrease 31% of cervical cancer. This is a technique that dates back to the first studies on early detection of this disease.
At present we have a multitude of techniques for the diagnosis of cervical cancer such as cytology, colposcopy and biopsy. Colposcopy makes it possible to locate possible lesions and, if necessary, to perform a biopsy to rule out cancer in the area. It can also detect lesions in the vagina and vulva by means of vaginoscopy and vulvoscopy and even helps to detect HPV.
The aim of the screening program is to detect premalignant lesions and cancer in its early stages. Specifically, it is recommended for women between 25 and 65 years of age as well as those vaccinated against HPV. It consists of a painless and simple test in which a sample of cells lining the cervix is taken and then sent to the laboratory for analysis.
If HPV is not detected or the cytology is negative, the risk of developing premalignant lesions is minimal. Let us remember that it is very important to maintain proper coordination of the tests along with proper transmission of this information to the patient. In addition, it is advisable to avoid undergoing this type of invasive tests and surgical treatments since it can be detrimental to the patient’s health.